Landmark 30-year study on Crigler-Najjar syndrome underscores the need for new therapies

April 16, 2020

STRASBURG, PA- A new study summarizes more than 30 years of clinical experience and describes the clinical course of 28 individuals homozygous for damaging mutations in the UGT1A1 gene who were born between 1984 and 2015 with Crigler-Najjar syndrome. This morbid and life-threatening disorder is characterized by high levels of toxic bilirubin in the blood which can lead to irreversible brain damage or death. The study yields novel insights about the pathophysiology of bilirubin encephalopathy, demonstrates principles of effective phototherapy, and provides a framework to judge emerging molecular therapies. The project was a broad collaborative effort led by clinicians and researchers at the Clinic for Special Children (CSC) and appears in the journal Hepatology.

The study cohort was followed for 520 aggregate patient-years and provided critical data regarding the effectiveness of phototherapy and liver transplantation therapies. Researchers used an index of neurological risk by measuring unbound ("free") bilirubin in patient blood sera to determine the binding of unconjugated bilirubin to albumin. Four infants (14%) developed brain damage between 14 and 45 days of life, demonstrating the need for early intervention for Crigler-Najjar syndrome.

Two different systems of blue light therapy (i.e. phototherapy) were used to control bilirubin levels in the blood. Researchers found that starting phototherapy as early as possible is crucial; treatment delayed for more than 13 days after birth increased the risk of brain damage 3.5-fold. Consistent phototherapy kept bilirubin levels within safe limits throughout childhood, but average blood bilirubin increased with advancing age to reach dangerous concentrations by age 18 years.

Liver transplantation restored nearly 100% functional UGT1A1 enzyme activity and provided protection from brain damage. Seventeen (60%) of 28 patients received a liver transplant at a median age of 16.2 years. Bilirubin levels decreased dramatically within days after transplant and remained stable thereafter, eliminating the need for daily phototherapy. Post-transplant graft and patient survival were 100%. The researchers noted while liver transplantation provides an effective therapy, it entails well established short- and long-term risks.

Based on these observations, the authors conclude that despite advances in clinical care, Crigler-Najjar Syndrome remains a morbid and potentially fatal disorder, and there remains a critical unmet need for safer and more effective disease-modifying interventions that leverage emerging gene replacement and editing technologies.

Clinic for Special Children

Related Brain Damage Articles from Brightsurf:

Early details of brain damage in COVID-19 patients
Looking at six patients using a specialized magnetic resonance technique, researchers at Massachusetts General Hospital found that COVID-19 patients with neurological symptoms show some of the same metabolic disturbances in the brain as other patients who have suffered oxygen deprivation from other causes, but there are also notable differences.

Brain metastases cause severe brain damage that can be inhibited by treatment
By using a specific treatment to override this activation, the researchers were able to return cerebrovascular flow to healthy levels.

MRI reveals brain damage in obese teens
Researchers using MRI have found signs of damage that may be related to inflammation in the brains of obese adolescents, according to a new study.

New approach to stroke treatment could minimize brain damage
A new treatment for a common type of stroke may soon be possible, thanks to a discovery by an international team of researchers led by the University of British Columbia.

A 15-minute scan could help diagnose brain damage in newborns
A 15-minute scan could help diagnose brain damage in babies up to two years earlier than current methods.

Cocaine adulterant may cause brain damage
People who regularly take cocaine cut with the animal anti-worming agent levamisole demonstrate impaired cognitive performance and a thinned prefrontal cortex.

Four out of 10 patients with atrial fibrillation have unknown brain damage
Four out of 10 patients with atrial fibrillation but no history of stroke or transient ischemic attack have previously unknown brain damage, according to the first results of the Swiss Atrial Fibrillation Cohort Study (Swiss-AF) presented today at ESC Congress 2018.

Zika brain damage may go undetected in pregnancy
Zika virus may cause significant damage to the fetal brain even when the baby's head size is normal, according to a primate study.

New study: Traumatic brain injury causes intestinal damage
Researchers have found a two-way link between traumatic brain injury and intestinal changes.

Brain damage in fish affected by plastic nanoparticles
A new study from Lund University in Sweden shows that plastic particles in water may end up inside fish brains.

Read More: Brain Damage News and Brain Damage Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to